Paper
1 July 1991 Nd:YAG laser treatment in patients with prostatic adenocarcinoma stage A
Franco Gaboardi M.D., Ernesto Dotti, Andrea Bozzola, Luigi Galli
Author Affiliations +
Proceedings Volume 1421, Lasers in Urology, Laparoscopy, and General Surgery; (1991) https://doi.org/10.1117/12.43907
Event: Optics, Electro-Optics, and Laser Applications in Science and Engineering, 1991, Los Angeles, CA, United States
Abstract
This paper describes laser irradiation in the prostatic adenocarcinoma of stage A. Prostatic adenocarcinoma is an unsuspected prostatic tumor, incidentally discovered during an hystologic examination after TURP or adenectomy, limited to the prostate. Sixteen patients with hystological diagnosis of prostatic carcinoma of stage A (12 A1 and 4 A2) entered the trial. After ultrasound control of the reduced prostatic tissue to a thin residual capsule an endoscopic and percutaneous irradiation with endoscopic Nd:YAG laser was performed. Average follow-up is 18 months (range 6-48). All patients had negative biopsies. No tumor had progressed. There were no side effects, both potency and continence were unchanged. The results are promising and comparable to short-term results obtained with conventional treatment.
© (1991) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Franco Gaboardi M.D., Ernesto Dotti, Andrea Bozzola, and Luigi Galli "Nd:YAG laser treatment in patients with prostatic adenocarcinoma stage A", Proc. SPIE 1421, Lasers in Urology, Laparoscopy, and General Surgery, (1 July 1991); https://doi.org/10.1117/12.43907
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors

Aluminum

Laser tissue interaction

Biopsy

Nd:YAG lasers

Laser irradiation

Ultrasonography

Back to Top